ERBB2 and neoplasm: Thus, it seems possible to identify tumor markers, the change in which was characteristic only of HER2-positive subtypes of breast cancer (non-luminal and luminal B(+)), namely EGFR2, CA15-3, CA27.29, MCA, and CA19-9 (Table 5).